University of Minnesota at ObesityWeek 2026

Nov 14–17, 2026 National Harbor, MD ~4.4k attendees Website

University of Minnesota brings 18 presentations to ObesityWeek 2026 in National Harbor. Its program centers on treating obesity in children and adolescents, from younger children aged 6 to 12 to teens with type 2 diabetes. Highlights include efficacy and safety results from the SURMOUNT-ADOLESCENTS trial and a randomized trial comparing lifestyle treatment with pharmacotherapy in adolescents.

OrganizationObesityWeek 2026 Attendance
Universities & research institutes
Public land-grant research university in Minneapolis and Saint Paul with a medical school.
Session
Fri Nov 13
1:00pm–6:15pm
Pediatric Obesity: Comprehensive Care and Practical Strategies for Today's Clinician - Day 1
Practical course for clinicians on pediatric obesity care, combining nutrition, behavior therapy and newer drugs, with case simulations and workflow strategies.
with Wake Forest University, Obesity Action Coalition, UT Southwestern Medical Center
Clinical obesity care and professional practiceObesity pharmacotherapy and drug developmentPediatric and adolescent obesityNutrition, diet and food
Talk
Fri Nov 13
4:30pm–5:15pm
Pharmacotherapy
Clinical obesity care and professional practiceObesity pharmacotherapy and drug developmentPediatric and adolescent obesityNutrition, diet and food
Session
Sat Nov 14
8:00am–12:45pm
Pediatric Obesity: Comprehensive Care and Practical Strategies for Today's Clinician - Day 2
Interprofessional course on pediatric obesity care, covering nutrition counseling, behavior therapy, newer medicines, special populations and clinic efficiency.
with Wake Forest University, Obesity Action Coalition
Clinical obesity care and professional practiceObesity pharmacotherapy and drug developmentPediatric and adolescent obesityNutrition, diet and food
Session
Sun Nov 15
8:30am–9:30am
From Kids to Older Adults: Should the "Healthy" Use GLP-1s?
Debates whether GLP-1 drugs should be used by metabolically healthy children and adults, weighing benefits, growth in youth, nutrition, equity and resource use.
Population health and epidemiologyClinical obesity care and professional practicePediatric and adolescent obesityObesity pharmacotherapy and drug development
Session
Sun Nov 15
12:00pm–1:00pm
TOS Clinical Science Section Meeting (TOS members only) - Ethical and Statistical Considerations for Obesity Research in 2026 and Beyond
Two experts discuss the ethics of placebo arms in obesity drug trials and statistical designs that limit placebo exposure and handle rescue therapy.
Woodrow Wilson, Ballroom Level
with University of North Carolina at Chapel Hill, United States Military Academy
Interventional and clinical studies
Talk
Sun Nov 15
6:10pm–6:15pm
SURMOUNT-ADOLESCENTS: Efficacy and Patient-Reported Outcomes
Woodrow Wilson, Ballroom Level
Interventional and Clinical Studies · Pediatrics · Chronic Disease
Talk
Sun Nov 15
6:20pm–6:30pm
SURMOUNT-ADOLESCENTS: Safety
Woodrow Wilson, Ballroom Level
Interventional and Clinical Studies · Pediatrics · Chronic Disease
Session
Mon Nov 16
10:00am–11:30am
Semaglutide for the Treatment of Childhood Obesity: Results of the STEP-YOUNG Trial
Interventional and Clinical Studies · Pediatrics · Pharmacology · Chronic Disease · with Yale University
Poster
Mon Nov 16
2:30pm–3:30pm
Talk
Mon Nov 16
4:15pm–4:30pm
Lifestyle Treatment Versus Pharmacotherapy in Adolescents with Obesity: A Randomized Trial
Interventional and Clinical Studies · Pediatrics · Metabolism and Integrative Physiology · Chronic Disease
Session
Mon Nov 16
5:00pm–6:30pm
The Wonder Years: Treatment of Obesity in Younger Children, 6-12 Years
Reviews research and treatment for obesity in children under 12, including off-label medicines and genetic syndromes, with case examples of combined approaches.
Interventional and clinical studiesClinical obesity care and professional practicePolicy and public healthNutrition, diet and foodPediatric and adolescent obesityObesity pharmacotherapy and drug development
Talk
Mon Nov 16
5:00pm–5:20pm
Pharmacologic Treatment of Younger Children: Newer and Off-label Therapies
Interventional and clinical studiesClinical obesity care and professional practicePolicy and public healthNutrition, diet and foodPediatric and adolescent obesityObesity pharmacotherapy and drug development

Explore the full ObesityWeek 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in National Harbor. Leave your work email and we’ll be in touch.

Privacy

Download the full ObesityWeek 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at University of Minnesota

Tell us what you sell and we’ll find the people at University of Minnesota most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by The Obesity Society (TOS), ObesityWeek® or the American Society for Metabolic and Bariatric Surgery (ASMBS). Submit a correction